Acute Tubular Necrosis
Understanding Acute Tubular Necrosis (ATN): This resource provides information on ATN, also known as acute renal failure and renal tubular necrosis, including clinical documentation, medical coding, diagnosis, and treatment considerations for healthcare professionals. Learn about the causes, symptoms, and management of ATN for accurate clinical documentation and appropriate medical coding.
Kidney injury leading to acute impairment of renal function. Can be caused by ischemia or toxins.
Decreased urine output, fluid retention, electrolyte imbalances, elevated creatinine and BUN.
Hospitalized patients, post-surgery, severe infections, dehydration, exposure to nephrotoxic drugs.
ICD-10 Code Families
Complete code families applicable to N17.0
When to use each related code
| Description | When to use |
|---|---|
| Kidney damage leading to acute kidney failure. | Use for rapid decline in kidney function due to tubular cell damage. Consider causes like ischemia or toxins. |
| Sudden kidney failure due to reduced blood flow to the kidneys. | Use when decreased renal perfusion is the primary cause of acute kidney injury. Code specific cause if known (e.g., shock). |
| Gradual loss of kidney function over time. | Use for chronic, progressive kidney damage, often associated with other conditions like diabetes or hypertension. |
Best-practice checklist
- ✓ATN diagnosis: Document causative agent (e.g., nephrotoxins, ischemia)
- ✓Acute Tubular Necrosis: Specify stage (initiation, maintenance, recovery)
- ✓Acute Renal Failure: Document serum creatinine, BUN, and urine output
- ✓Renal tubular necrosis: Include RIFLE or AKIN criteria assessment
- ✓ATN coding: Use ICD-10 code N17.9 for unspecified ATN
Common pitfalls to avoid
Coding ATN requires specifying cause (e.g., ischemic, nephrotoxic) for accurate reimbursement and data analysis. Unspecified ATN may lead to claim denials.
Acute Renal Failure is a broader term. Coding should reflect the specific diagnosis of ATN when confirmed, avoiding general coding that impacts quality metrics.
Complete clinical documentation of ATN staging (if applicable) is crucial for proper severity coding and accurate reflection of patient acuity.
Best-practice tips
- 01Hydration: Maintain euvolemia, monitor I/O, ICD-10 N17.9, N17
- 02Nephrotoxic drugs: Review meds, avoid NSAIDs, aminoglycosides, SNOMED CT 264821001
- 03Contrast: Minimize use, pre-hydrate, monitor renal function, CPT 74170
- 04Rhabdomyolysis: Prompt treatment, monitor CK, ICD-10 R82.3, LOINC 3842-7
- 05Hypotension: Maintain BP, avoid hypovolemia, ICD-10 I95.9, I95.1
Step-by-step checklist
- 1
Verify elevated creatinine, BUN, oliguria documented (ICD-10 N17.9, N17.8)
- 2
Assess for nephrotoxic drug exposure, hypotension (patient safety)
- 3
Fractional excretion of sodium calculation performed and documented
- 4
Consider renal biopsy if diagnosis uncertain (clinical documentation)
Ready-to-paste narrative
Patient presents with acute kidney injury (AKI), suggestive of acute tubular necrosis (ATN). Clinical presentation includes oliguria with decreased urine output and elevated serum creatinine. Differential diagnosis considered prerenal azotemia and acute interstitial nephritis, but the patient's history of recent [mention specific cause e.g., hypotension during surgery, exposure to nephrotoxic contrast dye, or sepsis] supports the ATN diagnosis. Laboratory findings reveal elevated blood urea nitrogen (BUN) and creatinine, consistent with acute renal failure. Fractional excretion of sodium (FeNa) is elevated, further supporting the diagnosis of intrinsic renal failure due to ATN. Urinalysis shows granular casts and renal tubular epithelial cells, characteristic findings in ATN. The patient's medical history is significant for [mention relevant comorbidities, e.g., diabetes, hypertension, heart failure]. Current medications include [list current medications]. Plan includes aggressive fluid resuscitation, careful monitoring of electrolyte balance, particularly potassium and phosphorus, and discontinuation of any potentially nephrotoxic medications. Renal replacement therapy (dialysis) may be necessary if renal function does not improve. Patient education provided on the causes, symptoms, and treatment of acute tubular necrosis, including the importance of medication adherence and follow-up care. Prognosis for ATN is dependent on the underlying cause and the patient's overall health status. ICD-10 code N17.9 for acute kidney failure, unspecified will be utilized for billing and coding purposes. Close monitoring and supportive care are crucial for optimal patient outcomes.
Common questions and answers
How can I differentiate between pre-renal acute kidney injury and acute tubular necrosis (ATN) in a patient presenting with oliguria?+
Differentiating pre-renal AKI from ATN, especially in the setting of oliguria, can be challenging but crucial for guiding management. While both present with decreased urine output and elevated creatinine, several key features can help distinguish them. Pre-renal AKI often responds rapidly to fluid resuscitation, demonstrated by a prompt increase in urine output and improvement in creatinine. Look for signs of hypovolemia like orthostatic hypotension, dry mucous membranes, and decreased skin turgor. In contrast, ATN, characterized by damage to the renal tubules, is less responsive to fluid challenges. Urinary indices can offer additional clues. A fractional excretion of sodium (FeNa) less than 1% and a urine osmolality greater than 500 mOsm/kg suggest pre-renal AKI, indicating the kidneys are effectively conserving sodium and water. ATN typically presents with an FeNa greater than 2% and a lower urine osmolality, reflecting impaired tubular function. However, these indices can be less reliable in patients with chronic kidney disease or those receiving diuretics. Consider incorporating urinary biomarkers like NGAL and KIM-1, which have shown promise in early ATN diagnosis, to enhance your clinical assessment. Explore how these biomarkers can integrate into your diagnostic algorithm for acute kidney injury. Furthermore, a careful review of the patient's medication history, including nephrotoxic agents, can provide valuable insights. If the clinical picture remains unclear after initial assessment and fluid challenge, consider implementing a short-term trial of renal replacement therapy while further investigations are pursued. Learn more about the utility of renal biopsy in complex cases of acute kidney injury.
What are the best practices for preventing contrast-induced acute tubular necrosis (CIN) in high-risk patients undergoing CT scans?+
Contrast-induced acute tubular necrosis (CIN) is a significant concern in high-risk patients, particularly those with pre-existing chronic kidney disease, diabetes, or heart failure. Minimizing the risk requires a multi-faceted approach centered on patient selection, hydration, and contrast agent minimization. First, carefully assess the patient's renal function through eGFR calculation and consider alternative imaging modalities when appropriate. Adequate hydration is paramount. Isotonic saline administered 12 hours before and after contrast administration is the cornerstone of CIN prevention. The rate and duration of hydration should be individualized based on the patient's clinical status and comorbidities. Minimizing the volume of contrast media used is crucial. Utilize low-osmolar or iso-osmolar contrast agents whenever possible, as they are associated with a lower risk of CIN compared to high-osmolar agents. Consider implementing prophylactic strategies such as N-acetylcysteine, although its efficacy remains debated. Closely monitor renal function post-contrast administration, particularly in the first 48-72 hours. Explore how risk stratification tools can aid in identifying patients at highest risk of CIN and guide preventative strategies.
What are the long-term prognosis and potential complications of acute tubular necrosis (ATN) after recovering from the acute phase?+
While most patients with acute tubular necrosis (ATN) experience complete renal recovery, some may develop long-term complications. The extent of tubular damage, duration of AKI, and presence of comorbidities influence the prognosis. Potential long-term sequelae include chronic kidney disease (CKD), hypertension, and electrolyte abnormalities. Even after regaining seemingly normal renal function, some patients may progress to CKD over time. Closely monitoring renal function with serial eGFR measurements and urine analysis is essential in the months following ATN recovery. Patients should be counseled on lifestyle modifications, including dietary adjustments, blood pressure control, and avoidance of nephrotoxic medications, to mitigate the risk of CKD progression. Learn more about the role of renoprotective therapies in preventing long-term complications after ATN. Consider implementing strategies to optimize cardiovascular health, as cardiovascular disease is a major cause of morbidity and mortality in patients with CKD. Regular follow-up with a nephrologist is recommended for patients who experience delayed or incomplete recovery from ATN to ensure appropriate management of potential complications and optimize long-term renal outcomes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.